AGREEMENT CONTAINING CONSENT ORDERSDecember 28th, 2021
FiledDecember 28th, 2021The Federal Trade Commission (“Commission”), having initiated an investigation of the proposed acquisition of VersaPharm Incorporated by Akorn, Inc. (“Proposed Respondent”), and it now appearing that Proposed Respondent is willing to enter into this Agreement Containing Consent Orders (“Consent Agreement”) to divest certain assets and providing for other relief: